Bundamedik Tbk vs Selaras Citra Nusantara Perkasa Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 259.7K 24h volume), while Selaras Citra Nusantara Perkasa Tbk. trades at Rp149 (market cap 377.5B, 438.1K 24h volume). The key difference: Bundamedik Tbk is far larger — about 4× Selaras Citra Nusantara Perkasa Tbk.'s market cap, and Selaras Citra Nusantara Perkasa Tbk. is more actively traded (438.1K versus 259.7K). Which is the better fit depends on your goals.
| BMHS | SCNP | |
|---|---|---|
Market Cap | 1.51T | 377.5B |
Volume | 259.7K | 438.1K |
Lot | 2.6K | 4.38K |
Turnover | 45.69M | 68.41M |
Average Price | 175.91 | 156.16 |
Value | 45.69M | 68.41M |
Indicative Equilibrium Price | 177 | 151 |
Indicative Equilibrium Volume | 108 | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Selaras Citra Nusantara Perkasa (the Company),located in Bogor, was established based on Notarial Deed of Sukawaty Sumadi, SH. No. 12 dated 24 January 2000. The Company’s commercial operations started in 2000.
Read more on SCNP →